365 related articles for article (PubMed ID: 34464621)
21. Cellular Uptake of Psychostimulants - Are High- and Low-Affinity Organic Cation Transporters Drug Traffickers?
Jensen O; Rafehi M; Gebauer L; Brockmöller J
Front Pharmacol; 2020; 11():609811. PubMed ID: 33551812
[TBL] [Abstract][Full Text] [Related]
22. Proton-Coupled Organic Cation Antiporter Contributes to the Hepatic Uptake of Matrine.
Wu C; Sun X; Feng C; Liu X; Wang H; Feng F; Zhang J
J Pharm Sci; 2016 Mar; 105(3):1301-6. PubMed ID: 26886331
[TBL] [Abstract][Full Text] [Related]
23. Pharmacophore-based discovery of inhibitors of a novel drug/proton antiporter in human brain endothelial hCMEC/D3 cell line.
Chapy H; Goracci L; Vayer P; Parmentier Y; Carrupt PA; Declèves X; Scherrmann JM; Cisternino S; Cruciani G
Br J Pharmacol; 2015 Oct; 172(20):4888-904. PubMed ID: 26220580
[TBL] [Abstract][Full Text] [Related]
24. Functional expression of organic cation/carnitine transporter 2 (OCTN2/SLC22A5) in human brain capillary endothelial cell line hCMEC/D3, a human blood-brain barrier model.
Okura T; Kato S; Deguchi Y
Drug Metab Pharmacokinet; 2014; 29(1):69-74. PubMed ID: 23877104
[TBL] [Abstract][Full Text] [Related]
25. Cocktail-Dosing Microdialysis Study to Simultaneously Assess Delivery of Multiple Organic-Cationic Drugs to the Brain.
Kitamura A; Okura T; Higuchi K; Deguchi Y
J Pharm Sci; 2016 Feb; 105(2):935-940. PubMed ID: 26554532
[TBL] [Abstract][Full Text] [Related]
26. [The blood-brain barrier transport mechanism controlling analgesic effects of opioid drugs in CNS].
Okura T; Higuchi K; Deguchi Y
Yakugaku Zasshi; 2015; 135(5):697-702. PubMed ID: 25948304
[TBL] [Abstract][Full Text] [Related]
27. Involvement of the pyrilamine transporter, a putative organic cation transporter, in blood-brain barrier transport of oxycodone.
Okura T; Hattori A; Takano Y; Sato T; Hammarlund-Udenaes M; Terasaki T; Deguchi Y
Drug Metab Dispos; 2008 Oct; 36(10):2005-13. PubMed ID: 18606742
[TBL] [Abstract][Full Text] [Related]
28. Transport characteristics of tramadol in the blood-brain barrier.
Kitamura A; Higuchi K; Okura T; Deguchi Y
J Pharm Sci; 2014 Oct; 103(10):3335-41. PubMed ID: 25175482
[TBL] [Abstract][Full Text] [Related]
29. Molecular cloning, functional characterization and tissue distribution of rat H+/organic cation antiporter MATE1.
Terada T; Masuda S; Asaka J; Tsuda M; Katsura T; Inui K
Pharm Res; 2006 Aug; 23(8):1696-701. PubMed ID: 16850272
[TBL] [Abstract][Full Text] [Related]
30. Pharmacophore-Based Discovery of Substrates of a Novel Drug/Proton-Antiporter in the Human Brain Endothelial hCMEC/D3 Cell Line.
Smirnova M; Goracci L; Cruciani G; Federici L; Declèves X; Chapy H; Cisternino S
Pharmaceutics; 2022 Jan; 14(2):. PubMed ID: 35213988
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the discriminative stimulus effects of dimethyltryptamine with different classes of psychoactive compounds in rats.
Gatch MB; Rutledge MA; Carbonaro T; Forster MJ
Psychopharmacology (Berl); 2009 Jul; 204(4):715-24. PubMed ID: 19288085
[TBL] [Abstract][Full Text] [Related]
32. Evidence of carrier-mediated transport in the penetration of donepezil into the rat brain.
Kim MH; Maeng HJ; Yu KH; Lee KR; Tsuruo T; Kim DD; Shim CK; Chung SJ
J Pharm Sci; 2010 Mar; 99(3):1548-66. PubMed ID: 19691109
[TBL] [Abstract][Full Text] [Related]
33. Proteomics-Based Transporter Identification by the PICK Method: Involvement of TM7SF3 and LHFPL6 in Proton-Coupled Organic Cation Antiport at the Blood-Brain Barrier.
Kurosawa T; Tega Y; Uchida Y; Higuchi K; Tabata H; Sumiyoshi T; Kubo Y; Terasaki T; Deguchi Y
Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015309
[TBL] [Abstract][Full Text] [Related]
34. Functional characterization of mouse organic anion transporting peptide 1a4 in the uptake and efflux of drugs across the blood-brain barrier.
Ose A; Kusuhara H; Endo C; Tohyama K; Miyajima M; Kitamura S; Sugiyama Y
Drug Metab Dispos; 2010 Jan; 38(1):168-76. PubMed ID: 19833843
[TBL] [Abstract][Full Text] [Related]
35. Increased penetration of diphenhydramine in brain via proton-coupled organic cation antiporter in rats with lipopolysaccharide-induced inflammation.
Kawase A; Chuma T; Irie K; Kazaoka A; Kakuno A; Matsuda N; Shimada H; Iwaki M
Brain Behav Immun Health; 2021 Jan; 10():100188. PubMed ID: 34589723
[TBL] [Abstract][Full Text] [Related]
36. Saturable absorptive transport of the hydrophilic organic cation ranitidine in Caco-2 cells: role of pH-dependent organic cation uptake system and P-glycoprotein.
Bourdet DL; Thakker DR
Pharm Res; 2006 Jun; 23(6):1165-77. PubMed ID: 16741655
[TBL] [Abstract][Full Text] [Related]
37. Organic anion transporter 3 mediates the efflux transport of an amphipathic organic anion, dehydroepiandrosterone sulfate, across the blood-brain barrier in mice.
Miyajima M; Kusuhara H; Fujishima M; Adachi Y; Sugiyama Y
Drug Metab Dispos; 2011 May; 39(5):814-9. PubMed ID: 21325432
[TBL] [Abstract][Full Text] [Related]
38. The blood-brain barrier choline transporter.
Geldenhuys WJ; Allen DD
Cent Nerv Syst Agents Med Chem; 2012 Jun; 12(2):95-9. PubMed ID: 22483271
[TBL] [Abstract][Full Text] [Related]
39. Blood-brain and retinal barriers show dissimilar ABC transporter impacts and concealed effect of P-glycoprotein on a novel verapamil influx carrier.
Chapy H; Saubaméa B; Tournier N; Bourasset F; Behar-Cohen F; Declèves X; Scherrmann JM; Cisternino S
Br J Pharmacol; 2016 Feb; 173(3):497-510. PubMed ID: 26507673
[TBL] [Abstract][Full Text] [Related]
40. The poorly membrane permeable antipsychotic drugs amisulpride and sulpiride are substrates of the organic cation transporters from the SLC22 family.
Dos Santos Pereira JN; Tadjerpisheh S; Abu Abed M; Saadatmand AR; Weksler B; Romero IA; Couraud PO; Brockmöller J; Tzvetkov MV
AAPS J; 2014 Nov; 16(6):1247-58. PubMed ID: 25155823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
